Generic Pharmaceutical Companies Aid Haiti's Battle with Chikungunya
Health officials anticipate that up to 50 percent of the population will
be affected by the outbreak. The most recent numbers for Haiti record
nearly 65,000 suspected cases.
Apotex, Inc. donates more than $2.2 M in medical supplies to Direct
Relief for chikungunya response.
PORT-AU-PRINCE, Haiti, Sept. 10, 2014 /CNW/ - As the mosquito-borne
chikungunya virus continues to spread throughout the Americas,
humanitarian organization Direct Relief delivered enough medicines to
treat one million people - or nearly one in 10 Haitians - to its
warehouse in Port-au-Prince.
The shipment, designated for Haiti's 904 Public Health and Population
sites and Direct Relief's other partner hospitals, contains more than
6.1 million Defined Daily Doses of pain relievers, oral rehydration
packs, antibiotics, IV solution, malaria tablets, and mosquito spray.
Generic pharmaceutical company Apotex generously donated more than $2.2
million of the $2.6 million (wholesale) in medical aid.
"When a fast-spreading virus like chikungunya impacts people who already
struggle to access health care, it is important to provide hospitals
and clinics with the supplies they need to meet the growing demand for
care," said Jeff Watson, Apotex's President, US and Canada (Apotex
Corp/Aveva/Apotex Inc.) "Apotex is in a position to help, and we are
delighted to work with Direct Relief to fill those gaps."
Other contributors to this response include Generic Pharmaceutical
Association (GPHA) members Amneal, Hospira, and TEVA Pharmaceuticals,
along with 3M, Johnson & Johnson, McKesson, and Prestige Brands.
"It is difficult to imagine a more meaningful use for generic medicines
than helping people suffering from this frightening and debilitating
disease," said Ralph G. Neas, President and CEO of the Generic
Pharmaceutical Association. "These donations are a testament to the
shared goals of the generics industry- providing access to medications
for people who need them most."
Unlike many other mosquito-borne diseases, no vaccine is available to
prevent chikungunya. Common symptoms include fever and joint pain,
which is often severe and disabling.
The current outbreak, which began in late 2013, marked the arrival of
chikungunya in the Americas. It was first detected in Haiti in May and
its spread prompted the Haitian government to formally declare a
medical emergency. Health officials anticipate that up to 50 percent of
the population may be affected by the outbreak. To date, Haiti has
recorded roughly 65,000 cases.
Since Haiti's devastating earthquake in 2010, Direct Relief has worked
with the Haitian Ministry of Public Health and Population to deliver
more than $120 million in medical aid throughout the country.
About Direct Relief
Active in 70 countries and all 50 states, Direct Relief is among the
world's largest medical suppliers to Haiti, has top charity ratings,
including four-stars from Charity Navigator and a 100% fundraising
efficiency rating from Forbes magazine. Among other distinctions,
Direct Relief is recognized with the Power of Partnership Award from
the National Association of Community Health Centers, the Peter F.
Drucker Award for Nonprofit Innovation, and the President's Award from
Esri for excellence in GIS mapping. For more information visit www.DirectRelief.org.
Apotex is the largest Canadian owned pharmaceutical company with over
5,500 employees. Globally it has another approximately 4,500 employees
with estimated sales of approximately $2 billion. The company's
Canadian headquarters is based in Toronto, Ontario,. With its
worldwide manufacturing sites, Apotex can produce up to 24 billion
dosages per year. It produces 300 medicines in 4,000 dosages and
formats that are exported to 115 countries. It has 500 products under
development and will spend $2 billion over the next 10 years on
research and development.
Throughout its 40 year history, Apotex has responded to public health
crisis and natural disasters around the globe. In the last year,
Apotex has donated over $10 million of needed medicines to countries in
Africa, Central America, and the Caribbean.
SOURCE: Apotex Inc.
For further information:
For more info: Elie Betito